Connection

Robert Adams to Stroke

Back to Details
This is a "connection" page, showing publications Robert Adams has written about Stroke.
Robert Adams
Connection Strength
6.899
Stroke
  1. Effect of novel training to normalize altered finger force direction post-stroke: study protocol for a double-blind randomized controlled trial. Trials. 2022 Apr 12; 23(1):301.
    View in: PubMed
    Score: 0.330
  2. Transcranial Doppler Screening in a Current Cohort of Children With Sickle Cell Anemia: Results From the DISPLACE Study. J Pediatr Hematol Oncol. 2021 11 01; 43(8):e1062-e1068.
    View in: PubMed
    Score: 0.320
  3. New approaches to genetic predisposition for hemorrhagic stroke in sickle cell disease. J Clin Hypertens (Greenwich). 2018 06; 20(6):1078-1079.
    View in: PubMed
    Score: 0.252
  4. Commentary: Addressing Racial Disparities in Stroke: The Wide Spectrum Investigation of Stroke Outcome Disparities on Multiple Levels (WISSDOM). Ethn Dis. 2018; 28(1):61-68.
    View in: PubMed
    Score: 0.247
  5. Coexistent Sickle Cell Disease Has No Impact on the Safety or Outcome of Lytic Therapy in Acute Ischemic Stroke: Findings From Get With The Guidelines-Stroke. Stroke. 2017 03; 48(3):686-691.
    View in: PubMed
    Score: 0.230
  6. Transcranial doppler re-screening of subjects who participated in STOP and STOP II. Am J Hematol. 2016 12; 91(12):1191-1194.
    View in: PubMed
    Score: 0.226
  7. Prevention of stroke in sickle cell anemia. J Law Med Ethics. 2014; 42(2):135-8.
    View in: PubMed
    Score: 0.186
  8. Toward a stroke-free childhood in sickle cell disease: the 2013 Sherman Lecture. Stroke. 2013 Oct; 44(10):2930-4.
    View in: PubMed
    Score: 0.182
  9. Telestroke in South Carolina. J Stroke Cerebrovasc Dis. 2013 Oct; 22(7):946-50.
    View in: PubMed
    Score: 0.161
  10. Trends in comorbid sickle cell disease among stroke patients. J Neurol Sci. 2012 Feb 15; 313(1-2):86-91.
    View in: PubMed
    Score: 0.159
  11. Risk of recurrent stroke, myocardial infarction, or death in hospitalized stroke patients. Neurology. 2010 Feb 16; 74(7):588-93.
    View in: PubMed
    Score: 0.142
  12. Should TCD be used to force parents to allow transfusion? Pediatr Blood Cancer. 2010 Jan; 54(1):11-2.
    View in: PubMed
    Score: 0.141
  13. Influence of age on racial disparities in stroke admission rates, hospital charges, and outcomes in South Carolina. Stroke. 2009 Sep; 40(9):3096-101.
    View in: PubMed
    Score: 0.136
  14. Update to the AHA/ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attack. Stroke. 2008 May; 39(5):1647-52.
    View in: PubMed
    Score: 0.124
  15. Big strokes in small persons. Arch Neurol. 2007 Nov; 64(11):1567-74.
    View in: PubMed
    Score: 0.121
  16. Intra-individual variation in blood flow velocities in cerebral arteries of children with sickle cell disease. Pediatr Blood Cancer. 2007 Sep; 49(3):318-22.
    View in: PubMed
    Score: 0.120
  17. Transcranial Doppler ultrasonography in adults with sickle cell disease. Neurology. 2006 Aug 22; 67(4):572-4.
    View in: PubMed
    Score: 0.112
  18. Pathophysiology and treatment of stroke in sickle-cell disease: present and future. Lancet Neurol. 2006 Jun; 5(6):501-12.
    View in: PubMed
    Score: 0.110
  19. Trials in sickle cell disease. Pediatr Neurol. 2006 Jun; 34(6):450-8.
    View in: PubMed
    Score: 0.110
  20. Telestroke: extending stroke expertise into underserved areas. Lancet Neurol. 2006 Mar; 5(3):275-8.
    View in: PubMed
    Score: 0.108
  21. Prospective reliability of the STRokE DOC Wireless/Site Independent Telemedicine System. Neurology. 2006 Feb 14; 66(3):460.
    View in: PubMed
    Score: 0.108
  22. Organized stroke care. Stroke. 2006 Feb; 37(2):326-8.
    View in: PubMed
    Score: 0.107
  23. Discontinuing prophylactic transfusions used to prevent stroke in sickle cell disease. N Engl J Med. 2005 Dec 29; 353(26):2769-78.
    View in: PubMed
    Score: 0.107
  24. REACH: clinical feasibility of a rural telestroke network. Stroke. 2005 Sep; 36(9):2018-20.
    View in: PubMed
    Score: 0.104
  25. TCD in sickle cell disease: an important and useful test. Pediatr Radiol. 2005 Mar; 35(3):229-34.
    View in: PubMed
    Score: 0.100
  26. Can peak systolic velocities be used for prediction of stroke in sickle cell anemia? Pediatr Radiol. 2005 Jan; 35(1):66-72.
    View in: PubMed
    Score: 0.098
  27. Sickle cell disease: primary stroke prevention. CNS Spectr. 2004 Jun; 9(6):445-9.
    View in: PubMed
    Score: 0.096
  28. Stroke and conversion to high risk in children screened with transcranial Doppler ultrasound during the STOP study. Blood. 2004 May 15; 103(10):3689-94.
    View in: PubMed
    Score: 0.093
  29. Sickle cell disease and stroke: primary prevention and transcranial Doppler. Ann Neurol. 2003 Nov; 54(5):559-63.
    View in: PubMed
    Score: 0.092
  30. Remote evaluation of acute ischemic stroke: reliability of National Institutes of Health Stroke Scale via telestroke. Stroke. 2003 Oct; 34(10):e188-91.
    View in: PubMed
    Score: 0.091
  31. Coronary risk evaluation in patients with transient ischemic attack and ischemic stroke: a scientific statement for healthcare professionals from the Stroke Council and the Council on Clinical Cardiology of the American Heart Association/American Stroke Association. Circulation. 2003 Sep 09; 108(10):1278-90.
    View in: PubMed
    Score: 0.091
  32. Racial Differences in Blood Pressure Control Following Stroke: The REGARDS Study. Stroke. 2021 12; 52(12):3944-3952.
    View in: PubMed
    Score: 0.079
  33. Stroke prevention and treatment in sickle cell disease. Arch Neurol. 2001 Apr; 58(4):565-8.
    View in: PubMed
    Score: 0.077
  34. Transcranial Doppler (TCD) screening for stroke prevention in sickle cell anemia: pitfalls in technique variation. Pediatr Radiol. 2000 Nov; 30(11):733-8.
    View in: PubMed
    Score: 0.075
  35. Lessons from the Stroke Prevention Trial in Sickle Cell Anemia (STOP) study. J Child Neurol. 2000 May; 15(5):344-9.
    View in: PubMed
    Score: 0.072
  36. Stroke prevention in sickle cell disease. Curr Opin Hematol. 2000 Mar; 7(2):101-5.
    View in: PubMed
    Score: 0.071
  37. Practice patterns for stroke prevention using transcranial Doppler in sickle cell anemia: DISPLACE Consortium. Pediatr Blood Cancer. 2020 04; 67(4):e28172.
    View in: PubMed
    Score: 0.071
  38. Incomplete implementation of guideline-based stroke prevention therapy in sickle cell disease. Am J Hematol. 2018 09; 93(9):E222-E224.
    View in: PubMed
    Score: 0.064
  39. Differential Impact of Index Stroke on Dementia Risk in African-Americans Compared to Whites. J Stroke Cerebrovasc Dis. 2018 Oct; 27(10):2725-2730.
    View in: PubMed
    Score: 0.064
  40. Association of Sickle Cell Trait With Ischemic Stroke Among African Americans: A Meta-analysis. JAMA Neurol. 2018 07 01; 75(7):802-807.
    View in: PubMed
    Score: 0.063
  41. Medical University of South Carolina Telestroke: A Telemedicine Facilitated Network for Stroke Treatment in South Carolina-A Progress Report. Telemed J E Health. 2017 08; 23(8):674-677.
    View in: PubMed
    Score: 0.058
  42. Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia-TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trial. Lancet. 2016 Feb 13; 387(10019):661-670.
    View in: PubMed
    Score: 0.053
  43. Effect of Chronic Blood Transfusion on Biomarkers of Coagulation Activation and Thrombin Generation in Sickle Cell Patients at Risk for Stroke. PLoS One. 2015; 10(8):e0134193.
    View in: PubMed
    Score: 0.052
  44. Telestroke: variations in intravenous thrombolysis by spoke hospitals. J Stroke Cerebrovasc Dis. 2015 Apr; 24(4):739-44.
    View in: PubMed
    Score: 0.050
  45. Antihypertensive medication persistence 1-year post-stroke hospitalization. J Clin Hypertens (Greenwich). 2014 Dec; 16(12):869-74.
    View in: PubMed
    Score: 0.049
  46. The impact of ICD-9 revascularization procedure codes on estimates of racial disparities in ischemic stroke. J Stroke Cerebrovasc Dis. 2014 Nov-Dec; 23(10):2681-2686.
    View in: PubMed
    Score: 0.049
  47. Patient awareness and perception of stroke symptoms and the use of 911. J Stroke Cerebrovasc Dis. 2014 Oct; 23(9):2362-71.
    View in: PubMed
    Score: 0.049
  48. Persistent racial disparity in stroke hospitalization and economic impact in young adults in the buckle of stroke belt. Stroke. 2014 Jul; 45(7):1932-8.
    View in: PubMed
    Score: 0.048
  49. Magnetic resonance imaging/angiography and transcranial Doppler velocities in sickle cell anemia: results from the SWiTCH trial. Blood. 2014 Aug 07; 124(6):891-8.
    View in: PubMed
    Score: 0.048
  50. Genetic mapping and exome sequencing identify 2 mutations associated with stroke protection in pediatric patients with sickle cell anemia. Blood. 2013 Apr 18; 121(16):3237-45.
    View in: PubMed
    Score: 0.044
  51. MUSC's comprehensive stroke program: changing what's possible in stroke care across South Carolina. J S C Med Assoc. 2012 Oct-Dec; 108(5):128-31.
    View in: PubMed
    Score: 0.043
  52. Utilization of CT perfusion patient selection for mechanical thrombectomy irrespective of time: a comparison of functional outcomes and complications. J Neurointerv Surg. 2013 Nov; 5(6):518-22.
    View in: PubMed
    Score: 0.042
  53. Plasma BDNF and PDGF-AA levels are associated with high TCD velocity and stroke in children with sickle cell anemia. Cytokine. 2012 Oct; 60(1):302-8.
    View in: PubMed
    Score: 0.042
  54. Application of beta regression to analyze ischemic stroke volume in NINDS rt-PA clinical trials. Neuroepidemiology. 2011; 37(2):73-82.
    View in: PubMed
    Score: 0.040
  55. Effect of chronic transfusion therapy on progression of neurovascular pathology in pediatric patients with sickle cell anemia. Blood Cells Mol Dis. 2011 Aug 15; 47(2):125-8.
    View in: PubMed
    Score: 0.039
  56. Genetic predictors for stroke in children with sickle cell anemia. Blood. 2011 Jun 16; 117(24):6681-4.
    View in: PubMed
    Score: 0.039
  57. Effect of transfusion therapy on transcranial Doppler ultrasonography velocities in children with sickle cell disease. Pediatr Blood Cancer. 2011 May; 56(5):777-82.
    View in: PubMed
    Score: 0.038
  58. Heart disease and stroke statistics--2011 update: a report from the American Heart Association. Circulation. 2011 Feb 01; 123(4):e18-e209.
    View in: PubMed
    Score: 0.038
  59. Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011 Feb; 42(2):517-84.
    View in: PubMed
    Score: 0.038
  60. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the american heart association/american stroke association. Stroke. 2011 Jan; 42(1):227-76.
    View in: PubMed
    Score: 0.037
  61. Executive summary: heart disease and stroke statistics--2010 update: a report from the American Heart Association. Circulation. 2010 Feb 23; 121(7):948-54.
    View in: PubMed
    Score: 0.036
  62. Transcranial doppler ultrasonography (TCD) in infants with sickle cell anemia: baseline data from the BABY HUG trial. Pediatr Blood Cancer. 2010 Feb; 54(2):256-9.
    View in: PubMed
    Score: 0.035
  63. Prevalence of hypertension by duration and age at exposure to the stroke belt. J Am Soc Hypertens. 2010 Jan-Feb; 4(1):32-41.
    View in: PubMed
    Score: 0.035
  64. Heart disease and stroke statistics--2010 update: a report from the American Heart Association. Circulation. 2010 Feb 23; 121(7):e46-e215.
    View in: PubMed
    Score: 0.035
  65. Plasma interleukin-1beta concentration is associated with stroke in sickle cell disease. Cytokine. 2010 Jan; 49(1):39-44.
    View in: PubMed
    Score: 0.035
  66. Serum ferritin level changes in children with sickle cell disease on chronic blood transfusion are nonlinear and are associated with iron load and liver injury. Blood. 2009 Nov 19; 114(21):4632-8.
    View in: PubMed
    Score: 0.034
  67. Utilization of TCD screening for primary stroke prevention in children with sickle cell disease. Neurology. 2009 Apr 14; 72(15):1316-21.
    View in: PubMed
    Score: 0.033
  68. Independent association of HbA(1c) and incident cardiovascular disease in people without diabetes. Obesity (Silver Spring). 2009 Mar; 17(3):559-63.
    View in: PubMed
    Score: 0.033
  69. Cardiovascular disease risk associated with asthma and respiratory morbidity might be mediated by short-acting beta2-agonists. J Allergy Clin Immunol. 2009 Jan; 123(1):124-130.e1.
    View in: PubMed
    Score: 0.033
  70. A web-based telestroke system facilitates rapid treatment of acute ischemic stroke patients in rural emergency departments. J Emerg Med. 2009 Jan; 36(1):12-8.
    View in: PubMed
    Score: 0.031
  71. Using tPA for acute stroke in a rural setting. Neurology. 2007 May 29; 68(22):1957-8; author reply 1958.
    View in: PubMed
    Score: 0.029
  72. Obstacles to primary stroke prevention in children with sickle cell disease. Neurology. 2006 Sep 26; 67(6):1098-9.
    View in: PubMed
    Score: 0.028
  73. Elevated blood flow velocity in the anterior cerebral artery and stroke risk in sickle cell disease: extended analysis from the STOP trial. Br J Haematol. 2006 Aug; 134(3):333-9.
    View in: PubMed
    Score: 0.028
  74. Stroke Prevention Trial in Sickle Cell Anemia (STOP): extended follow-up and final results. Blood. 2006 Aug 01; 108(3):847-52.
    View in: PubMed
    Score: 0.028
  75. Regular transfusion lowers plasma free hemoglobin in children with sickle-cell disease at risk for stroke. Stroke. 2006 Jun; 37(6):1424-6.
    View in: PubMed
    Score: 0.027
  76. Population comparison of two clinical approaches to the metabolic syndrome: implications of the new International Diabetes Federation consensus definition. Diabetes Care. 2005 Nov; 28(11):2777-9.
    View in: PubMed
    Score: 0.026
  77. Recommendations for the establishment of stroke systems of care: recommendations from the American Stroke Association's Task Force on the Development of Stroke Systems. Circulation. 2005 Mar 01; 111(8):1078-91.
    View in: PubMed
    Score: 0.025
  78. Recommendations for the establishment of stroke systems of care: recommendations from the American Stroke Association's Task Force on the Development of Stroke Systems. Stroke. 2005 Mar; 36(3):690-703.
    View in: PubMed
    Score: 0.025
  79. Remote evaluation of acute ischemic stroke in rural community hospitals in Georgia. Stroke. 2004 Jul; 35(7):1763-8.
    View in: PubMed
    Score: 0.024
  80. Declining stroke rates in Californian children with sickle cell disease. Blood. 2004 Jul 15; 104(2):336-9.
    View in: PubMed
    Score: 0.024
  81. Guidelines for the early management of patients with ischemic stroke: A scientific statement from the Stroke Council of the American Stroke Association. Stroke. 2003 Apr; 34(4):1056-83.
    View in: PubMed
    Score: 0.022
  82. Impact of chronic transfusion on incidence of pain and acute chest syndrome during the Stroke Prevention Trial (STOP) in sickle-cell anemia. J Pediatr. 2001 Dec; 139(6):785-9.
    View in: PubMed
    Score: 0.020
  83. Prospective RBC phenotype matching in a stroke-prevention trial in sickle cell anemia: a multicenter transfusion trial. Transfusion. 2001 Sep; 41(9):1086-92.
    View in: PubMed
    Score: 0.020
  84. Hydroxycarbamide treatment reduces transcranial Doppler velocity in the absence of transfusion support in children with sickle cell anaemia, elevated transcranial Doppler velocity, and cerebral vasculopathy: the EXTEND trial. Br J Haematol. 2021 11; 195(4):612-620.
    View in: PubMed
    Score: 0.020
  85. Sickle cell and the brain. Hematology Am Soc Hematol Educ Program. 2001; 31-46.
    View in: PubMed
    Score: 0.019
  86. Developing a risk-based composite neurologic outcome for a trial of hydroxyurea in young children with sickle cell disease. Clin Trials. 2019 02; 16(1):20-31.
    View in: PubMed
    Score: 0.016
  87. Characterization of intracranial atherosclerotic stenosis using high-resolution MRI study--rationale and design. Brain Behav. 2015 Dec; 5(12):e00397.
    View in: PubMed
    Score: 0.013
  88. Transcranial Direct Current Stimulation Post-Stroke Upper Extremity Motor Recovery Studies Exhibit a Dose-Response Relationship. Brain Stimul. 2016 Jan-Feb; 9(1):16-26.
    View in: PubMed
    Score: 0.013
  89. Frequent red cell transfusions reduced vascular endothelial activation and thrombogenicity in children with sickle cell anemia and high stroke risk. Am J Hematol. 2014 Jan; 89(1):47-51.
    View in: PubMed
    Score: 0.012
  90. Magnetic resonance angiography in children with sickle cell disease and abnormal transcranial Doppler ultrasonography findings enrolled in the STOP study. Blood. 2004 Apr 01; 103(7):2822-6.
    View in: PubMed
    Score: 0.006
  91. Correlation of abnormal intracranial vessel velocity, measured by transcranial Doppler ultrasonography, with abnormal conjunctival vessel velocity, measured by computer-assisted intravital microscopy, in sickle cell disease. Blood. 2001 Jun 01; 97(11):3401-4.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.